Journal Articles
The Benefits From Giving Makers Of Conventional ‘Small Molecule’ Drugs Longer Exclusivity Over Clinical Trial Data
January 17, 2011
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, John Romley, PhD, Tomas Philipson, PhD
Research
All Research Featured Research
Journal Articles
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older
July 5, 2009
Featured Experts: Dana Goldman, PhD
Journal Articles
The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries
January 17, 2009
Featured Experts: Neeraj Sood, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Articles
U.S. Pharmaceutical Policy In A Global Marketplace
January 1, 2009
Featured Experts: Darius Lakdawalla, PhD, Neeraj Sood, PhD, Dana Goldman, PhD